"Rivastigmine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
| Descriptor ID |
D000068836
|
| MeSH Number(s) |
D02.241.081.251.583.899
|
| Concept/Terms |
Rivastigmine- Rivastigmine
- (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
RivastigmineTartrate- RivastigmineTartrate
- Rivastigmine Hydrogen Tartrate
- Hydrogen Tartrate, Rivastigmine
- Tartrate, Rivastigmine Hydrogen
ENA 713- ENA 713
- 713, ENA
- SDZ ENA 713
- 713, SDZ ENA
- ENA 713, SDZ
- ENA-713
- ENA713
|
Below are MeSH descriptors whose meaning is more general than "Rivastigmine".
Below are MeSH descriptors whose meaning is more specific than "Rivastigmine".
This graph shows the total number of publications written about "Rivastigmine" by people in this website by year, and whether "Rivastigmine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rivastigmine" by people in Profiles.
-
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952.
-
Rivastigmine modifies the a-secretase pathway and potentially early Alzheimer's disease. Transl Psychiatry. 2020 02 03; 10(1):47.
-
Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. Int Psychogeriatr. 2007 Jun; 19(3):539-58.